BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17635584)

  • 1. UXT interacts with the transcriptional repressor protein EVI1 and suppresses cell transformation.
    McGilvray R; Walker M; Bartholomew C
    FEBS J; 2007 Aug; 274(15):3960-71. PubMed ID: 17635584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9a.
    Spensberger D; Delwel R
    FEBS Lett; 2008 Aug; 582(18):2761-7. PubMed ID: 18619962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid transforming protein Evi1 interacts with methyl-CpG binding domain protein 3 and inhibits in vitro histone deacetylation by Mbd3/Mi-2/NuRD.
    Spensberger D; Vermeulen M; Le Guezennec X; Beekman R; van Hoven A; Bindels E; Stunnenberg H; Delwel R
    Biochemistry; 2008 Jun; 47(24):6418-26. PubMed ID: 18500823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced sensitivity to hydrogen peroxide-induced apoptosis in Evi1 transformed Rat1 fibroblasts due to repression of carbonic anhydrase III.
    Roy P; Reavey E; Rayne M; Roy S; Abed El Baky M; Ishii Y; Bartholomew C
    FEBS J; 2010 Jan; 277(2):441-52. PubMed ID: 20015077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservation and expression of a novel alternatively spliced Evi1 exon.
    Alzuherri H; McGilvray R; Kilbey A; Bartholomew C
    Gene; 2006 Dec; 384():154-62. PubMed ID: 17014970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EVI1 recruits the histone methyltransferase SUV39H1 for transcription repression.
    Cattaneo F; Nucifora G
    J Cell Biochem; 2008 Oct; 105(2):344-52. PubMed ID: 18655152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evi-1 ZF1 DNA binding activity and a second distinct transcriptional repressor region are both required for optimal transformation of Rat1 fibroblasts.
    Kilbey A; Bartholomew C
    Oncogene; 1998 Apr; 16(17):2287-91. PubMed ID: 9619838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Evi-1 proto-oncogene encodes a transcriptional repressor activity associated with transformation.
    Bartholomew C; Kilbey A; Clark AM; Walker M
    Oncogene; 1997 Feb; 14(5):569-77. PubMed ID: 9053855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroviral insertional activation of the EVI1 oncogene does not prevent G-CSF-induced maturation of the murine pluripotent myeloid cell line 32Dcl3.
    Khanna-Gupta A; Lopingco MC; Savinelli T; Zibello T; Berliner N; Perkins AS
    Oncogene; 1996 Feb; 12(3):563-9. PubMed ID: 8637713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of oncogenic transformation by mammalian Lin-9, a pRB-associated protein.
    Gagrica S; Hauser S; Kolfschoten I; Osterloh L; Agami R; Gaubatz S
    EMBO J; 2004 Nov; 23(23):4627-38. PubMed ID: 15538385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconstitution of the KRAB-KAP-1 repressor complex: a model system for defining the molecular anatomy of RING-B box-coiled-coil domain-mediated protein-protein interactions.
    Peng H; Begg GE; Schultz DC; Friedman JR; Jensen DE; Speicher DW; Rauscher FJ
    J Mol Biol; 2000 Feb; 295(5):1139-62. PubMed ID: 10653693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of RUNX1 activity by EVI1: a new role of EVI1 in leukemogenesis.
    Senyuk V; Sinha KK; Li D; Rinaldi CR; Yanamandra S; Nucifora G
    Cancer Res; 2007 Jun; 67(12):5658-66. PubMed ID: 17575132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT.
    Liu Y; Chen L; Ko TC; Fields AP; Thompson EA
    Oncogene; 2006 Jun; 25(25):3565-75. PubMed ID: 16462766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZNF652, a novel zinc finger protein, interacts with the putative breast tumor suppressor CBFA2T3 to repress transcription.
    Kumar R; Manning J; Spendlove HE; Kremmidiotis G; McKirdy R; Lee J; Millband DN; Cheney KM; Stampfer MR; Dwivedi PP; Morris HA; Callen DF
    Mol Cancer Res; 2006 Sep; 4(9):655-65. PubMed ID: 16966434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel cervical cancer suppressor 3 (CCS-3) interacts with the BTB domain of PLZF and inhibits the cell growth by inducing apoptosis.
    Rho SB; Park YG; Park K; Lee SH; Lee JH
    FEBS Lett; 2006 Jul; 580(17):4073-80. PubMed ID: 16828757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evi-1 transforming and repressor activities are mediated by CtBP co-repressor proteins.
    Palmer S; Brouillet JP; Kilbey A; Fulton R; Walker M; Crossley M; Bartholomew C
    J Biol Chem; 2001 Jul; 276(28):25834-40. PubMed ID: 11328817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia.
    Meyers S; Lenny N; Sun W; Hiebert SW
    Oncogene; 1996 Jul; 13(2):303-12. PubMed ID: 8710369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of the corepressor TLE1 to Qin enhances Qin-mediated transformation of chicken embryo fibroblasts.
    Sonderegger CK; Vogt PK
    Oncogene; 2003 Mar; 22(12):1749-57. PubMed ID: 12660810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Evi1 proto-oncoprotein blocks endomitosis in megakaryocytes by inhibiting sustained cyclin-dependent kinase 2 catalytic activity.
    Kilbey A; Alzuherri H; McColl J; Calés C; Frampton J; Bartholomew C
    Br J Haematol; 2005 Sep; 130(6):902-11. PubMed ID: 16156860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.